৳ 0.00
Your Complete HealthCare Solution - Right Here
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.
৳ 0.00
10657
info@shukhee.com
Telecom Bhaban (Level- 12), 53/1 Box Nagar, Zoo Road, Dhaka-1216.


Quantity:
Products
Payment
Delivery
Hypertension: Treatment of essential hypertension in adults.
Cardiovascular prevention: Reduction of cardiovascular morbidity in adults with:
Atherothrombotic cardiovascular disease (history of coronary heart disease, stroke, or peripheral arterial disease), or
Type 2 diabetes mellitus with documented target organ damage.
Telmisartan is a non‑peptide angiotensin II receptor antagonist.
Angiotensin II is formed from angiotensin I by ACE and is the main agent of the renin‑angiotensin system, causing vasoconstriction, aldosterone release, cardiac stimulation, and sodium reabsorption.
Telmisartan selectively blocks angiotensin II binding to AT1 receptors in vascular smooth muscle and adrenal gland.
It does not inhibit ACE, so bradykinin response is unaffected.
Telmisartan has >3,000‑fold higher affinity for AT1 than AT2 receptors.
Usual starting dose: 40 mg once daily.
Dose range: 20–80 mg daily.
Effect appears within 2 weeks, maximal after 4 weeks.
Elderly or renal impairment: monitor closely, especially dialysis patients (risk of orthostatic hypotension).
May be given with or without food, and with other antihypertensives.
Not recommended as initial therapy in patients ≥75 years or with hepatic impairment.
Pediatric use: Safety not established.
Geriatric use: No overall differences observed.
Hepatic impairment: Monitor carefully and titrate slowly.
NSAIDs: Increased risk of renal impairment and reduced antihypertensive effect.
Aliskiren: Avoid co‑administration in diabetic patients.
Known hypersensitivity to Telmisartan or any component.
In hypertensive patients: sinus pain, congestion, back pain, diarrhea.
In CV risk reduction: intermittent claudication, skin ulcer.
Pregnancy Category C (first trimester) and D (second/third trimester).
May cause adverse effects on fetus and nursing infant.
Decide whether to discontinue nursing or the drug, considering importance to mother.
Avoid fetal/neonatal exposure.
Monitor hypotension, hepatic or renal impairment.
Avoid concomitant use of ACE inhibitors and ARBs.
Most likely: hypotension, dizziness, tachycardia, bradycardia.
Possible: increased serum creatinine, acute renal failure due to vagal stimulation.




$4f
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Telmivas 20 mg Tablet may be taken with or without food, but it is better to take it at a fixed time.
Telmivas 20 mg Tablet is an angiotensin receptor blocker (ARB). It relaxes blood vessels by blocking the action of a chemical that usually makes blood vessels tighter. This lowers the blood pressure, allowing the blood to flow more smoothly to different organs and the heart to pump more efficiently.
If you miss a dose of Telmivas 20 mg Tablet, skip it and continue with your normal schedule. Do not double the dose.





